We are live on
!
Find out more
DCOY
Decoy Therapeutics
DCOY
DCOY
3 hedge funds and large institutions have $2.01K invested in Decoy Therapeutics in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.02% less ownership
Funds ownership: 0.03% → 0.01% (-0.02%)
63% less funds holding
Funds holding: 8 → 3 (-5)
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
98% less capital invested
Capital invested by funds: $104K → $2.01K (-$102K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Holders
3
Holders Change
-5
Holders Change %
-62.5%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$3.87K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$461 |
Top Sellers
| 1 |
HF
HRT Financial
New York
|
-$28K |
| 2 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$15K |
| 3 |
Goldman Sachs
New York
|
-$14.9K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$13.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$9.13K |